Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-003284-31Phase 3Terminated
Phase 3, open-label, single-arm trial of oseltamivir in influenza, sponsored by Roche. Primary endpoints: Safety of seasonal prophylaxis with oseltamivir and Efficacy of oseltamivir for seasonal prophylaxis. Started Oct 2006; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-003284-31.